학술논문
It is likely that the risk of cardiovascular events from pharmaceuticals as COX-2 inhibitors can be reduced significantly by standard pharmaceutical and lifestyle preventative measures
Document Type
Article
Author
Source
In Medical Hypotheses 2006 67(6):1333-1337
Subject
Language
ISSN
0306-9877